Posttransplant Lymphoproliferative Disease after Lung Transplantation
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...
Autor principal: | |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Hindawi Limited
2013-01-01
|
Colección: | Clinical and Developmental Immunology |
Acceso en línea: | http://dx.doi.org/10.1155/2013/430209 |